
GB40168
Daglutril
Also listed as Daglutril - SLV 306
An orally active, dual endothelin converting enzyme (ECE)/neutral endopeptidase (NEP) inhibitor that reduces proteinuria and urinary albumin excretion in diabetic rats· Simultaneous augmentation of ANP and inhibition of ET-1 production by Daglutril treatment is of potential therapeutic benefit in cardiovascular disease, and for treatment of overt nephropathy and reduction of albuminuria in hypertensive patients with type 2 diabetes
ChemicalCAS182821-27-8MW534.64FormulaC31H38N2O6
- CAS number
- 182821-27-8
- Molecular weight
- 534.64
- Formula
- C31H38N2O6
- InChIKey
- XMQODGUTLZXUGZ-RPBOFIJWSA-N
- Catalogue number
- GB40168
- Brand
- GLPBIO
Computed properties PubChem CID 3038505 · XLogP 4.9 · TPSA 113 Ų · H-bond donors 2
- XLogP
- 4.9
- TPSA
- 113 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 12
- Heavy atoms
- 39
SMILES CCOC(=O)[C@H](CCC1=CC=CC=C1)CC2(CCCC2)C(=O)N[C@H]3CCC4=CC=CC=C4N(C3=O)CC(=O)O
Computed descriptors from PubChem (CID 3038505), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il